Erythroid-specific Human Factor IX Delivery From In Vivo Selected Hematopoietic Stem Cells Following Nonmyeloablative Conditioning in Hemophilia B Mice

We have developed a lentiviral vector system for human factor IX (hFIX) gene transfer in hematopoietic stem cells (HSCs) that provides erythroid cell-derived systemic protein delivery following nonmyeloablative conditioning and in vivo methylguanine methyltransferase (MGMT) drug selection. After bon...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Chang, Alex H, Stephan, Matthias T, Lisowski, Leszek, Sadelain, Michel
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2658893/
https://ncbi.nlm.nih.gov/pubmed/18682698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2008.161
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires